ÂÜÀòÂÒÂ×

Coline Burnet-Merlin has had a diverse range of roles and experiences in the field of biomedical research.

Starting in 2016, Coline worked as a Stagiaire at the Institut de Biologie Structurale (IBS), where they specialized in the purification of Providencia stuartii porins. Coline'sresponsibilities included using FPLC and SDS-PAGE techniques for purification, studying bacterial growth, conducting imaging with épi-fluorescence, and utilizing mutagenesis techniques such as bacterial transformation and PCR.

After completing their role at IBS, Coline moved on to work as an Assistante de recherche en alternance at SMARTOX from August 2017 to August 2018.

In 2018, they began their Master's degree in Sciences du médicament at Université Claude Bernard Lyon 1, which they completed in 2020. During this time, they further developed their expertise in the field.

Coline then joined the Novartis Institutes for BioMedical Research (NIBR) in January 2020, where they initially served as a Master Intern until July 2020. Coline then became a Post Graduate from July 2020 to November 2020, before being promoted to the role of Research Scientist I from November 2020 to June 2021. In these positions, they contributed to various research projects and furthered their understanding of biomedical research.

Most recently, Coline has started working as a Research Assistant at Light Chain Bioscience | Novimmune SA in June 2021.

Overall, Coline Burnet-Merlin has gained valuable skills and experience in the biotechnology and biomedical research field through their various roles and educational pursuits.

Coline Burnet-Merlin's education history begins in 2014 when they attended Lycée Jean-Moulin in Albertville (73) and obtained a Baccalauréat in Sciences (SVT) in 2015. Coline then enrolled in Lycée Louise Michel in Grenoble for the period of 2016 to 2017, where they completed a BTS degree in Bioanalyses et contrôles. In 2017, they attended Université Grenoble Alpes, but no specific degree was mentioned. From 2018 to 2020, Coline pursued their Master's degree in Sciences du Médicament with a focus on Sciences pharmaceutiques at Université Claude Bernard Lyon 1.